Nucleic acid amplification technologies are used for the rapid and accurate diagnosis of chronic and infectious diseases. The nucleic acid amplification is one of the important tool for wide aspects of life science technologies including, clinical medicine development, diagnosis of infectious diseases, and gene cloning. Extensively increasing prevalence of chronic as well as infectious diseases is boosting the demand for state-of-the-art diagnostic systems.
Cyberdyne, Myomo Inc, – Notable Market Players in Rehabilitation Robots Market
Market leaders operating in the market have undertaken various organic growth strategies in the Rehabilitation Robots market. The Rehabilitation Robots market majorly consists of the players such as Bionik Laboratories Corporation, Cyberdyne Inc., Ekso Bionics Holdings Inc, Rewalk Robotics Ltd, Hocoma Ag, Rehab-robotics Company Limited, Kinova Inc, Rex Bionics Ltd, Toyota Motor Corporation, Myomo Inc among others. Several organic as well as inorganic approaches, such as product launches, and expansion, mergers & acquisition, collaborations in the Rehabilitation Robots market, have resulted in the positive growth of the market. Product launches help the company to strengthen its product offering and the customer base, which allows the company to hold a strong position in the market.
Below is the list of the growth strategies done by the players operating in the Rehabilitation Robots market :
| Month & Year | News |
| Jan-2017 | Rex Bionics Plc announced that the ethics committee of the UK NHS’s National Institute for Health Research had approved the start of a clinical trial to evaluate the use of the REX robotic mobility device in patients with multiple sclerosis (MS). |
| Nov-2019 | Toyota Motor Corporation launched its new Welwalk WW-2000, a robot designed to provide rehabilitation support to individuals with lower-limb paralysis due to stroke and other causes. |
| Jun-2020 | BIONIK Laboratories Corp. announced the debut of its InMotion Connect platform, a comprehensive solution designed to address the data connectivity and analytics requirements of hospitals and healthcare facilities across the country. |
| Aug-2020 | Myomo reported that the first insurance authorization to fit a patient with a personalized MyoPro device has been granted by a Myomo-trained Orthotic & Prosthetic (“O&P”) practice in Australia. |
| Nov-2020 | Myomo, Inc. has announced the launch of MyoGames by Lusio, a video gaming platform meant to support MyoPro users’ training and rehabilitation while also being enjoyable. |
| Jan-2017 | Rex Bionics Plc announced that the ethics committee of the UK NHS’s National Institute for Health Research had approved the start of a clinical trial to evaluate the use of the REX robotic mobility device in patients with multiple sclerosis (MS). |
